β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)

PHASE3CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Acute Gouty Arthritis Flares
Interventions
DRUG

ACZ885

canakinumab 150 mg s.c., given on demand upon new flares

DRUG

Triamcinolone acetonide 40 mg

Participants received 40 mg intramuscular (IM)

Trial Locations (56)

2010

Novartis Investigative Site, Darlinghurst

10138

Novartis Investigative Site, Tallinn

13419

Novartis Investigative Site, Tallinn

23606

Novartis Investigative Site, Newport News

24541

Novartis Investigative Site, Danville

28602

Novartis Investigative Site, Hickory

29204

Novartis Investigative Site, Columbia

29407

Novartis Investigative Site, Charleston

29412

Novartis Investigative Site, Charleston

29944

Novartis Investigative Site, Varnville

30035

Novartis Investigative Site, Decatur

32584

Novartis Investigative Site, Löhne

33458

Novartis Investigative Site, Jupiter

33756

Novartis Investigative Site, Clearwater

36608

Novartis Investigative Site, Mobile

37043

Novartis Investigative Site, Clarksville

37601

Novartis Investigative Site, Johnson City

37620

Novartis Investigative Site, Bristol

39110

Novartis Investigative Site, Magdeburg

39202

Novartis Investigative Site, Jackson

39209

Novartis Investigative Site, Jackson

44094

Novartis Investigative Site, Willoughby Hills

45402

Novartis Investigative Site, Dayton

48085

Novartis Investigative Site, Troy

48532

Novartis Investigative Site, Flint

50009

Novartis Investigative Site, Kaunas

59804

Novartis Investigative Site, Missoula

66215

Novartis Investigative Site, Overland Park

66606

Novartis Investigative Site, Topeka

67208

Novartis Investigative Site, Wichita

68114

Novartis Investigative Site, Omaha

69035

Novartis Investigative Site, Zaporizhzhya

70006

Novartis Investigative Site, Metairie

70570

Novartis Investigative Site, Opelousas

86159

Novartis Investigative Site, Augsburg

88009

Novartis Investigative Site, Uzhhorod

90650

Novartis Investigative Site, Norwalk

91105

Novartis Investigative Site, Pasadena

92108

Novartis Investigative Site, San Diego

92288

Novartis Investigative Site, Klaipėda

92780

Novartis Investigative Site, Tustin

115522

Novartis Investigative Site, Moscow

150003

Novartis Investigative Site, Yaroslavl

185019

Novartis Investigative Site, Petrozavodsk

190068

Novartis Investigative Site, Saint Petersburg

620219

Novartis Investigative Site, Yekaterinburg

36207-5710

Novartis Investigative Site, Anniston

07728

Novartis Investigative Site, Freehold

A1B 5E8

Novartis Investigative Site, St. John's

A1C 5B8

Novartis Investigative Site, St. John's

A1E 2C2

Novartis Investigative Site, St. John's

G1V 3M7

Novartis Investigative Site, Sainte-Foy

LV-4201

Novartis Investigative Site, Valmiera

LT-76231

Novartis Investigative Site, Šiauliai

09020

Novartis Investigative Site, Vilnius

LT-08661

Novartis Investigative Site, Vilnius

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY